Tang Yong-Bo, Wang Qian-Lei, Zhu Bing-Yang, Huang Hong-Lin, Liao Duan-Fang
Institute of Pharmacy and Pharmacology, Nanhua University, Hengyang 421001, China.
Sheng Li Xue Bao. 2005 Jun 25;57(3):373-8.
This study examined whether genistein influences the production of nitric oxide (NO) and expression of endothelial nitric oxide synthase (eNOS) and the modulators of eNOS activity in ovariectomized (OVX) rat hearts. Female mature Sprague-Dawley rats were subjected to bilateral ovariectomy, OVX rats were randomly divided into four groups: 17beta-estradiol (0.1 mg/kg, s.c. daily) was used as the positive control; low dose of genistein (0.5 mg/kg, s.c. daily); high dose of genistein (5.0 mg/kg, s.c. daily) and model. Sham operations as controls, the treatment lasted 6 weeks. Blood pressure, heart rate, plasma estradiol, heart and uterine weights were measured. Nitrite production in the myocardium was determined by nitrate reductase method. Protein level of eNOS, caveolin-1 and calmodulin was determined by Western blot. The results showed that nitrite production and eNOS protein in homogenized ventricular tissue was attenuated by approximately 53% and 67% in OVX rats compared with those in sham rats, respectively. Genistein increased nitrite production in rat heart in a dose-dependent manner, genistein at the dose of 5 mg/kg.d(-1) resumed nitrite production to a level similar to that in sham operated rats. Administration of genistein also increased eNOS protein expression in OVX rats myocardium with a concomitant decrease in the expression of caveolin-1, an endogenous eNOS inhibitory protein. Another eNOS stimulatory protein, calmodulin, was unchanged in these treatments. These effects were also observed in rats treated with 17beta-estradiol. Genistein at the dose of 5.0 mg/kg.d(-1) augmented uterine weight but this side effect in reproductive system was less than that of 17beta-estradiol. These results suggest that genistein supplementation and estrogen replacement therapy directly increase eNOS functional activity and NO production in the hearts of the OVX rats, but genistein has less side effects on the reproductive system than 17beta-estradiol.
本研究检测了染料木黄酮是否会影响去卵巢(OVX)大鼠心脏中一氧化氮(NO)的生成、内皮型一氧化氮合酶(eNOS)的表达以及eNOS活性的调节剂。将雌性成年Sprague-Dawley大鼠进行双侧卵巢切除,OVX大鼠被随机分为四组:17β-雌二醇(0.1 mg/kg,皮下注射,每日一次)用作阳性对照;低剂量染料木黄酮(0.5 mg/kg,皮下注射,每日一次);高剂量染料木黄酮(5.0 mg/kg,皮下注射,每日一次)以及模型组。假手术作为对照,治疗持续6周。测量血压、心率、血浆雌二醇、心脏和子宫重量。采用硝酸还原酶法测定心肌中亚硝酸盐的生成。通过蛋白质免疫印迹法测定eNOS、小窝蛋白-1和钙调蛋白的蛋白水平。结果显示,与假手术大鼠相比,OVX大鼠心室组织匀浆中亚硝酸盐的生成和eNOS蛋白分别减少了约53%和67%。染料木黄酮以剂量依赖性方式增加大鼠心脏中亚硝酸盐的生成,5 mg/kg.d(-1)剂量的染料木黄酮使亚硝酸盐生成恢复到与假手术大鼠相似的水平。给予染料木黄酮还增加了OVX大鼠心肌中eNOS蛋白的表达,同时内源性eNOS抑制蛋白小窝蛋白-1的表达降低。另一种eNOS刺激蛋白钙调蛋白在这些处理中未发生变化。在接受17β-雌二醇治疗的大鼠中也观察到了这些效应。5.0 mg/kg.d(-1)剂量的染料木黄酮增加了子宫重量,但这种对生殖系统的副作用小于17β-雌二醇。这些结果表明,补充染料木黄酮和雌激素替代疗法可直接增加OVX大鼠心脏中eNOS的功能活性和NO的生成,但染料木黄酮对生殖系统的副作用比17β-雌二醇小。